Med BioGene Responds to Assertions Made by Dissident Shareholder
August 21, 2014 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 21, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today responded to the recent assertions made by Iain Weir-Jones, the dissident shareholder...
Med BioGene Provides Update and Announces Proposed Financing
August 15, 2014 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 15, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update to its shareholders and announced a proposed financing.
...
Med BioGene Announces Director Nominations and Postponement of Annual and Special Meeting
August 06, 2014 15:42 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 6, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that a shareholder has submitted nominations pursuant to MBI's Advance...
Med Biogene Reports Financial Results for Q1 2014
May 30, 2014 22:11 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 30, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the three months ended March 31, 2014 (all amounts...
Med BioGene Reports Financial Results for 2013
April 30, 2014 15:08 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 30, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the year ended December 31, 2013 (all amounts are...
Med BioGene Announces Regulatory Approval of GeneFx(R) Lung
March 24, 2014 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that its commercial partner, Precision Therapeutics, Inc. has received...
Med BioGene Announces Publication of Data Demonstrating Independent Validation of GeneFx(R) Lung
March 07, 2014 08:30 ET
|
Med BioGene Inc.;GeneFx
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 7, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today announced the publication in the Journal of Thoracic Oncology of data demonstrating a...
Med BioGene Provides GeneFx(R) Lung Regulatory Update
February 05, 2014 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 5, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today provided an update on the regulatory approval process for GeneFx® Lung.
...
Med BioGene Announces Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC
January 09, 2014 08:30 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 9, 2014) - Med BioGene Inc. (TSX VENTURE:MBI) today announced that, pursuant to a previously announced settlement agreement among MBI, its...
Med BioGene Reports Financial Results for Q3 2013
November 29, 2013 21:39 ET
|
Med BioGene Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 29, 2013) - Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results for the nine months ended September 30, 2013 (all...